POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Enacted

Oklahoma creates Ensuring Transparency in Prescription Drugs Prior Authorization Act

Original title: Health insurance; creating the Ensuring Transparency in Prescription Drugs Prior Authorization Act; determination; consultation; prior authorization; effective date.

Last action · May 29, 2025: Becomes law without Governor's signature 05/29/2025Sponsors: Cyndi Munson and 8 others

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Does

Oklahoma law establishes the Ensuring Transparency in Prescription Drugs Prior Authorization Act, setting strict decision deadlines, mandatory disclosure of clinical criteria, and a three-year validity period for chronic condition drug approvals. The measure applies to health plans, pharmacy benefits managers, and the Oklahoma Medicaid State Plan beginning November 1, 2025.

Why it matters

Enrollees and health care providers face new procedural timelines and transparency requirements when requesting and appealing prescription drug coverage approvals, with penalties up to $5,000 per violation enforceable by state regulators.

Background
  • The State of Oklahoma operates under constitutional guidelines where bills passed by both legislative chambers can become law without the Governor's signature after a set period, as occurred with this measure on May 29, 2025. context

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Enrollees

Enrollees receive mandatory notification of prior authorization changes, benefit from three-year validity periods for chronic conditions, and experience structured timelines for urgent and nonurgent drug approvals.

Directly affected

Health care providers

Health care providers gain accessible online clinical criteria, mandatory 60-day advance notice of requirement changes, and automatic authorization if review entities miss decision deadlines.

Directly affected

Utilization review entities

Utilization review entities must publish clinical criteria, ensure qualified medical personnel review adverse determinations and appeals, and comply with strict turnaround timeframes.

Directly affected

Pharmacy benefits managers

Pharmacy benefits managers are subject to transparency rules, qualification standards for adverse determinations, and potential penalties of up to $5,000 per violation enforced by the Attorney General.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

How quickly must health plans decide prior authorization requests?
Decisions for urgent prescription drugs must be made within 24 hours of obtaining all necessary information, while nonurgent prescription drug requests must be decided within four business days.
How long does a prior authorization last for a chronic condition?
For chronic conditions, a prior authorization remains valid for three years from the approval date, provided the enrollee stays on the same health plan and clinical criteria or tiers do not change.
Are emergency prescription drugs subject to prior authorization?
No, utilization review entities are prohibited from requiring prior authorization for prescription drugs administered as part of emergency health care services.
What happens if a health plan misses the deadline to approve or deny a request?
If a provider submits all necessary information through the 's authorized prior authorization system and the entity fails to meet statutory deadlines, the prescription drugs are deemed authorized.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Current status: Became law without the governor's signature.

Procedural history

47 actions
  1. May 29, 2025House
    Becomes law without Governor's signature 05/29/2025
  2. May 22, 2025House
    Sent to Governor
  3. May 22, 2025Senate
    Enrolled measure signed, returned to House
  4. May 22, 2025House
    Enrolled, signed, to Senate
  5. May 22, 2025HouseCommittee
    Referred for enrollment
  6. May 22, 2025SenateFloor
    Measure passed, to House: Ayes: 42 Nays: 0
Show 41 earlier actions
  1. May 22, 2025SenateFloor
    CCR adopted, GCCA
  2. May 22, 2025Senate
    CCR read, GCCA
  3. May 22, 2025House
    To Senate
  4. May 22, 2025HouseFloor
    Fourth Reading, Measure passed: Ayes: 80 Nays: 7
  5. May 22, 2025HouseFloor
    CCR adopted
  6. May 21, 2025House
    Enacting clause restored
  7. May 21, 2025House
    Title restored
  8. May 21, 2025House
    Coauthored by Representative(s) Menz, Alonso-Sandoval
  9. May 21, 2025House
    CCR submitted
  10. May 15, 2025Senate
    Conference granted, GCCA
  11. May 15, 2025HouseCommittee
    HC's named: Conference Committee on Commerce and Economic Development Oversight
  12. May 14, 2025House
    SA's rejected, conference requested, conferees to be named later
  13. May 12, 2025House
    SA's received
  14. May 12, 2025Senate
    Engrossed to House
  15. May 8, 2025SenateCommittee
    Referred for engrossment
  16. May 8, 2025SenateFloor
    Measure passed: Ayes: 42 Nays: 1
  17. May 8, 2025Senate
    General Order, Considered
  18. Apr 28, 2025Senate
    Placed on General Order
  19. Apr 23, 2025Senate
    Enacting clause stricken
  20. Apr 23, 2025SenateFloor
    Reported Do Pass as amended Appropriations committee; CR filed
  21. Apr 10, 2025SenateCommittee
    Referred to Appropriations
  22. Apr 10, 2025SenateFloor
    Reported Do Pass Business and Insurance committee; CR filed
  23. Apr 7, 2025Senate
    Coauthored by Senator Stanley
  24. Apr 1, 2025SenateCommittee
    Second Reading referred to Business and Insurance Committee then to Appropriations Committee
  25. Mar 25, 2025SenateIntroduced
    First Reading
  26. Mar 25, 2025House
    Engrossed, signed, to Senate
  27. Mar 24, 2025HouseCommittee
    Referred for engrossment
  28. Mar 24, 2025HouseFloor
    Third Reading, Measure passed: Ayes: 88 Nays: 7
  29. Mar 24, 2025House
    Title stricken
  30. Mar 24, 2025House
    Amended
  31. Mar 24, 2025House
    Amended by floor substitute
  32. Mar 24, 2025House
    Coauthored by Representative(s) Pae, Miller, Munson, Dempsey, Lawson
  33. Mar 24, 2025House
    General Order
  34. Mar 10, 2025House
    Coauthored by Representative(s) Deck
  35. Mar 10, 2025HouseFloor
    CR; Do Pass, amended by committee substitute Commerce and Economic Development Oversight Committee
  36. Feb 25, 2025House
    Authored by Senator Rader (principal Senate author)
  37. Feb 25, 2025HouseFloor
    Policy recommendation to the Commerce and Economic Development Oversight committee; Do Pass, amended by committee substitute Insurance
  38. Feb 4, 2025HouseCommittee
    Referred to Insurance
  39. Feb 4, 2025HouseCommittee
    Second Reading referred to Commerce and Economic Development Oversight
  40. Feb 3, 2025House
    Authored by Representative Newton
  41. Feb 3, 2025HouseIntroduced
    First Reading

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Introduction of Mandated Prior Authorization Timelines

The legislation enforces rigid hourly and daily response limits for urgent and nonurgent prescription drug requests, altering standard insurance review operations.

Connected Entities

Insurance Commissioner, State of Oklahoma, Attorney General and 3 more
OrganizationInsurance Commissioner“Empowered to impose penalties for violations and publish formularies”Map →
locationState of Oklahoma“Governing jurisdiction enacting the legislation”Map →
OrganizationAttorney General“Empowered to impose penalties on pharmacy benefits managers for violations”Map →
OrganizationBoard of Pharmacy“Licenses pharmacists in the state”Map →
OrganizationOklahoma Statutes“Legal code being amended by the act”Map →
OrganizationOklahoma Medicaid State Plan“State plan subject to the provisions of this act”Map →

Sources

Open source document

www.oklegislature.gov

Analysis Score

0–100
  • Significance85
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record